ACP-196 Alone and in Combination With Pembrolizumab in Subjects With Recurrent Ovarian Cancer (KEYNOTE191) - Adventist HealthCare

Clinical Trial Details

KEYNOTE191

ACP-196 Alone and in Combination With Pembrolizumab in Subjects With Recurrent Ovarian Cancer (KEYNOTE191)

Purpose/Objective

Request Additional Trial Information
Full Trial Details: ClinicalTrials.gov

Condition: Ovarian Cancer
Study Type: Interventional
Phase: Phase II
Study Start Date: 08/28/2015
Study Completion Date: TBD

To characterize the safety and efficacy of ACP 196 monotherapy and ACP-196 plus pembrolizumab in subjects with recurrent ovarian cancer.

NCT Number
NCT02537444
Principal Investigator(s)
Frederick Min, MD
Sponsor(s)
Acerta Pharma BV
Participant Eligibility
  • Age: 18 - No Maximum
  • Gender: Female

Location

  • Shady Grove Adventist Aquilino Cancer Center
    9905 Medical Center Drive
    Rockville, MD 20850
    Main: 240-826-6297

Find a Doctor

Find an Adventist HealthCare affiliated doctor by calling our FREE physician referral service at 800-642-0101 or by searching our online physician directory.

View Doctors

Set Your Location

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.